Changes in Parents’ COVID-19 Vaccine Hesitancy for Children Aged 3–17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys

Author:

Zhou Xiaofeng,Wang ShiyuORCID,Zhang Kechun,Chen SiyuORCID,Chan Paul Shing-fong,Fang YuanORCID,Cao He,Chen Hongbiao,Hu Tian,Chen Yaqi,Wang ZixinORCID

Abstract

China started to implement COVID-19 vaccination programs for children in July 2021. This study investigated the changes in parents’ COVID-19 vaccine hesitancy for children before and after the vaccination program rollout. Repeated cross-sectional online surveys among full-time adult factory workers were conducted in Shenzhen, China. This analysis was based on 844 (first round) and 1213 parents (second round) who had at least one child aged 3–17 years. The prevalence of vaccine hesitancy for children aged 3–11 years dropped from 25.9% (first round) to 17.4% (second round), while such a prevalence for children aged 12–17 years dropped from 26.0% (first round) to 3.5% (second round) (p < 0.001). Positive attitudes, a perceived subjective norm, and perceived behavioral control related to children’s COVID-19 vaccination were associated with lower vaccine hesitancy in both rounds. In the second round and among parents with children aged 3–11 years, negative attitudes and exposure to information on SARS-CoV-2 infection after receiving a primary vaccine series were associated with higher vaccine hesitancy, while exposure to experiences shared by vaccine recipients and infectiousness of variants of concern were associated with lower vaccine hesitancy. Regular monitoring of vaccine hesitancy and its associated factors among parents should be conducted to guide health promotion.

Funder

The study was funded by the High-Level Project of Medicine in Longhua, Shenzhen and the Key Discipline of Infectious Diseases Control and Prevention of Long Hua

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference72 articles.

1. COVID-19 deaths in children: comparison with all- and other causes and trends in incidence of mortality

2. Coronavirus Disease 2019 (COVID-19) in Children: Vulnerable or Spared? A Systematic Review

3. Demographic Trends of COVID-19 Cases and Deaths in the US Reported to CDC 2022;CentersforDiseaseControlandPrevention

4. Number of Coronavirus (COVID-19) Cases in Germany in 2022, by Age Group and Gender 2022 https://www.statista.com/statistics/1105465/coronavirus-covid-19-cases-age-group-germany/

5. Number of the Coronavirus (COVID-19) Cases in India as of October 18, 2021, by Age Group 2022 https://www.statista.com/statistics/1110522/india-number-of-coronavirus-cases-by-age-group/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3